idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
Science Video Project
idw-Abo

idw-News App:

AppStore

Google Play Store



Instanz:
Teilen: 
01.06.2018 08:36

Targeting platelets

Dr. Daniela Diefenbacher Public Science Center
Rudolf-Virchow-Zentrum für Experimentelle Biomedizin der Universität Würzburg

    A new Collaborative Research Center will start in July with a total funding of nearly 14 million euros, headed by the German Institute for Experimental Biomedicine in Würzburg. The aim is to decode the complex and insufficiently understood functions of platelets, the so-called thrombocytes. The scientists hope to use these findings to gain new insights into platelet research which allow better treatment of conditions such as heart attack, stroke, acute lung failure and cancer.

    "Thrombocytes do much more than to stop bleedings and to cause heart attacks," explains Professor Bernhard Nieswandt, Director of the Institute for Experimental Biomedicine, supported by the University Hospital Würzburg (UKW) and the Rudolf Virchow Center for Experimental Biomedicine of the Julius-Maximilians-Universität Würzburg (JMU), Germany. "Recent studies have suggested that there are very complex interactions between the smallest blood cells and various inflammatory processes, cellular defense mechanisms, innate immunity, the maintenance of vascular and organ functions and the development of tumors." According to Professor Nieswandt a more detailed knowledge of the underlying molecular mechanisms is central to a better understanding of diseases such as stroke and acute respiratory failure.

    In collaboration with the University of Tübingen, Germany

    The outstanding importance of platelet research was also confirmed by the DFG (Deutsche Forschungsgemeinschaft): They recently approved the Collaborative Research Center Transregio (SFB / TR 240) "Thrombocytes - molecular, cellular and systemic functions under physiological and pathological conditions". The SFB TR 240 is funded with 13.7 million euros, for an initial term of four years, starting on July 1, 2018.
    The Würzburg Institute for Experimental Biomedicine was leading the application. Prof. Dr. med. Meinrad Gawaz, Director of the Medical Clinic III (Cardiology) of the University of Tübingen, was co-applicant. Both institutions have longstanding research programs on platelets.

    From bench to bedside: Basic research, but close to clinical application

    "The very pronounced translational character that unites basic researchers with clinicians is one special strength of our network", emphasizes Professor Nieswandt and specifies: "We are positive that our newly gained basic findings will quickly lead to novel treatment concepts for a whole series of Diseases that have not previously been seen in the context of platelets. "
    Prof. Dr. med. Georg Ertl, Medical Director of the UKW, says proudly with regard to the reputation of the location: "The DFG reviewers confirmed with this grant approval that Professor Nieswandt and his team are among the world elite in fundamental platelet research. Research for our patients is one of our outstanding duties."

    Scientists from the Greifswald University Hospital and the Dortmund Leibniz Institute for Analytical Sciences (ISAS) are also involved in the new Collaborative Research Center. The interdisciplinary research group combines molecular genetics, in vivo disease models, high resolution microscopy, in vivo imaging, systems biology, translational approaches and clinical research.

    Scientific Background
    Each day, around 100 billion platelets are produced from giant progenitor cells in the bone marrow of a healthy person, circulating in the bloodstream for about ten days. Their best-described function is to control the vessel wall for injury, sealing it if necessary in order to prevent uncontrolled blood loss. If uncontrolled thrombus formation occurs, platelets can form large aggregates, big enough to lead to life-threatening vascular occlusions such as in the case of a heart attack or stroke.

    Person
    Since the year 2002 Professor Nieswandt works in various capacities at the JMU. After studying biology and biochemistry, he completed his doctorate at the University of Regensburg and habilitated in the field of experimental medicine at the University of Witten / Herdecke, Germany. Since 2008, he has held the Chair of Experimental Biomedicine with focus on Vascular Biology and is Head of the Institute for Experimental Biomedicine, which is jointly supported by the University Hospital Würzburg (UKW) and the Rudolf Virchow Center for Experimental Biomedicine at the JMU. Since April 2016, he is part of the dual leadership of the Rudolf Virchow Center for Experimental Biomedicine.
    Further information on the Nieswandt research group on the Rudolf Virchow Center website under Research: www.rudolf-virchow-zentrum.de/forschung/arbeitsgruppen/ag-nieswandt/forschung.html

    Prof. Dr. Bernhard Nieswandt (Chair of Experimental Biomedicine with focus on Vascular Biology, Rudolf Virchow Center)
    Tel. +49 (0)9 31/ 31 - 80405, bernhard.nieswandt@virchow.uni-wuerzburg.de

    Susanne Just (Stabsstelle Kommunikation, Universitätsklinikum Würzburg
)
    Tel. +49 (0)931 / 201-59447, presse@ukw.de

    Dr. Daniela Diefenbacher (Press Office, Rudolf Virchow Center)
    Tel. +49 (0)931 3188631, daniela.diefenbacher@uni-wuerzburg.de


    Weitere Informationen:

    http://www.rudolf-virchow-zentrum.de/en/news/news/article/blutplaettchen-im-visi...


    Bilder

    Emerging platelets (white arrows) are buded off by their progenitor cells, the megakaryocytes. Here the cytoskeletal components tubulin (green) and actin (red) and the nucleus (blue) are colored.
    Emerging platelets (white arrows) are buded off by their progenitor cells, the megakaryocytes. Here ...
    Rudolf Virchow Center of the Julius-Maximilians-Universität Würzburg
    None


    Merkmale dieser Pressemitteilung:
    Journalisten, Wissenschaftler, jedermann
    Biologie, Ernährung / Gesundheit / Pflege, Medizin
    überregional
    Forschungs- / Wissenstransfer, Forschungsprojekte
    Englisch


     

    Emerging platelets (white arrows) are buded off by their progenitor cells, the megakaryocytes. Here the cytoskeletal components tubulin (green) and actin (red) and the nucleus (blue) are colored.


    Zum Download

    x

    Hilfe

    Die Suche / Erweiterte Suche im idw-Archiv
    Verknüpfungen

    Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.

    Klammern

    Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).

    Wortgruppen

    Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.

    Auswahlkriterien

    Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).

    Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).